• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.

作者信息

Levine Irving, Swaminath Arun, Roitman Isabel, Sultan Keith

机构信息

Division of Gastroenterology, North Shore University Hospital/Northwell Health, Manhasset, New York.

Division of Gastroenterology, Lennox Hill Hospital/Northwell Health, New York, New York.

出版信息

Gastroenterology. 2022 Jan;162(1):349-350. doi: 10.1053/j.gastro.2021.05.030. Epub 2021 May 18.

DOI:10.1053/j.gastro.2021.05.030
PMID:34015337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8129780/
Abstract
摘要

相似文献

1
COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.2019冠状病毒病疫苗接种与炎症性肠病：理想的抗体反应、未来方向及注意事项
Gastroenterology. 2022 Jan;162(1):349-350. doi: 10.1053/j.gastro.2021.05.030. Epub 2021 May 18.
2
SARS-CoV-2 vaccination for patients with inflammatory bowel disease.针对炎症性肠病患者的新型冠状病毒2型疫苗接种
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):523. doi: 10.1016/S2468-1253(21)00148-5.
3
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.炎症性肠病患者接种新型冠状病毒疫苗后新冠病毒突破性感染率较低
Inflamm Bowel Dis. 2023 Mar 1;29(3):483-486. doi: 10.1093/ibd/izac138.
4
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
5
COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.COVID-19 疫苗接种意向和炎症性肠病患者的认知。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1730-1732.e2. doi: 10.1016/j.cgh.2021.02.004. Epub 2021 Feb 4.
6
COVID-19 and Inflammatory Bowel Disease.新型冠状病毒肺炎与炎症性肠病。
Gastroenterol Clin North Am. 2023 Mar;52(1):103-113. doi: 10.1016/j.gtc.2022.10.005. Epub 2022 Oct 31.
7
Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种、既往SARS-CoV-2感染的抗体反应以及改为单剂量接种。
J Med Virol. 2021 Dec;93(12):6474. doi: 10.1002/jmv.27263. Epub 2021 Aug 12.
8
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease.炎症性肠病患者对三剂严重急性呼吸综合征冠状病毒2疫苗接种的血清学反应。
Gut. 2023 Apr;72(4):802-804. doi: 10.1136/gutjnl-2022-327440. Epub 2022 May 23.
9
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.巴西炎症性肠病研究小组关于新冠病毒疫苗接种的立场声明。
Arq Gastroenterol. 2021 Jan-Mar;58(1):1-4. doi: 10.1590/S0004-2803.202100000-02.
10
SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.炎症性肠病患者对SARS-CoV-2疫苗接种的恐惧与期望
Inflamm Bowel Dis. 2021 Oct 20;27(11):1858-1861. doi: 10.1093/ibd/izab150.

引用本文的文献

1
Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving -TNF therapy: A systematic review and meta-analysis.新冠病毒疫苗在接受肿瘤坏死因子治疗的炎症性肠病患者中的疗效：一项系统评价和荟萃分析。
Heliyon. 2023 Sep 5;9(9):e19609. doi: 10.1016/j.heliyon.2023.e19609. eCollection 2023 Sep.
2
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease.适用于患有自身免疫性肠道或肝脏疾病的成人和儿童的新冠疫苗。
Vaccines (Basel). 2022 Dec 5;10(12):2075. doi: 10.3390/vaccines10122075.
3
COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.炎症性肠病患者的新冠病毒疫苗接种：认知、疗效与安全性
Gastroenterol Hepatol (N Y). 2022 Jul;18(7):388-399.
4
Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review.比较 COVID-19 疫苗接种在炎症性肠病（IBD）患者中的效果和副作用：系统范围综述。
BMC Gastroenterol. 2022 Aug 20;22(1):393. doi: 10.1186/s12876-022-02460-1.
5
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease.2019冠状病毒病疫苗在炎症性肠病患者中的有效性和安全性
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):145-155.
6
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.新型冠状病毒疫苗在炎症性肠病患者中的安全性：系统评价和荟萃分析。
Dig Liver Dis. 2022 Jun;54(6):713-721. doi: 10.1016/j.dld.2022.03.005. Epub 2022 Mar 22.
7
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.新型冠状病毒疫苗在炎症性肠病患者中的有效性和安全性：系统评价、荟萃分析和荟萃回归。
Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. doi: 10.1111/apt.16913. Epub 2022 Mar 30.
8
Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.COVID-19 疫苗在 9447 例 IBD 患者中的有效性和持久性：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1456-1479.e18. doi: 10.1016/j.cgh.2022.02.030. Epub 2022 Feb 19.